Evidence map›Paper›PMID 12379631›Full record

ReviewAnnals of the rheumatic diseases2002

Tumour necrosis factor superfamily cytokines and the pathogenesis of inflammatory osteolysis.

J Lam, Y Abu-Amer, C A Nelson, D H Fremont, F P Ross, S L Teitelbaum

Abstract readReview
In one paragraph

Review in Annals of the rheumatic diseases, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Dextromethorphan inhibits osteoclast differentiation by suppressing RANKL-induced nuclear factor-κB activation.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. IKKbeta activation is sufficient for RANK-independent osteoclast differentiation and osteolysis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2010
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

J LamWashington University School of Medicine, St Louis MO 63110, USA.
Y Abu-Amer
C A Nelson
D H Fremont
F P Ross
S L Teitelbaum

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsArthritisCarrier ProteinsCell DifferentiationHumansMembrane GlycoproteinsOsteoclastsOsteolysisRANK LigandReceptor Activator of Nuclear Factor-kappa BStructure-Activity RelationshipTumor Necrosis Factor-alphaCarrier ProteinsMembrane GlycoproteinsRANK LigandReceptor Activator of Nuclear Factor-kappa BTNFRSF11A protein, humanTNFSF11 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID12379631
PMCPMC1766716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.